Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey P Schembri

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
International Journal of Radiation Oncology, Biology, Physics|July 14, 2020
Interim Results of a Prospective Prostate-Specific Membrane Antigen-Directed Focal Stereotactic Reirradiation Trial for Locally Recurrent Prostate CancerSarah Bergamin, Thomas Eade, Andrew Kneebone, et al.
Practical Radiation Oncology|May 7, 2018
Utilizing 18F-fluoroethyltyrosine (FET) positron emission tomography (PET) to define suspected nonenhancing tumor for radiation therapy planning of glioblastomaAimee R Hayes, Dasantha Jayamanne, Edward Hsiao, et al.
Journal of Medical Imaging and Radiation Oncology|January 25, 2019
Influence of molecular classification in anaplastic glioma for determining outcome and future approach to managementMichael Back, Dasantha T Jayamanne, David Brazier, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 2, 2022
<sup>64</sup>Cu Treatment Planning and <sup>67</sup>Cu Therapy with Radiolabeled [<sup>64</sup>Cu/<sup>67</sup>Cu]MeCOSar-Octreotate in Subjects with Unresectable Multifocal Meningioma: Initial Results for Human Imaging, Safety, Biodistribution, and Radiation DosimetryDale L Bailey, Kathy P Willowson, Matthew Harris, et al.
Theranostics|April 25, 2017
Dual Somatostatin Receptor/FDG PET/CT Imaging in Metastatic Neuroendocrine Tumours: Proposal for a Novel Grading Scheme with Prognostic SignificanceDavid Lh Chan, Nick Pavlakis, Geoffrey P Schembri, et al.
Pancreas|February 4, 2020
Evaluation of Fluorodeoxyglucose Positron Emission Tomography Scanning in the Neoadjuvant Therapy Paradigm in Pancreatic Ductal AdenocarcinomaMalinda Itchins, Terence C Chua, Jennifer Arena, et al.
Thyroid Research|June 16, 2025
The utility of <sup>68</sup>Ga-DOTATATE and <sup>18</sup>F-FDG PET/CT in predicting the response to tyrosine kinase inhibitors in patients with advanced medullary thyroid cancerEline C Jager, James McNeil, Alexander J Papachristos, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 10, 2023
Delineation and agreement of FET PET biological volumes in glioblastoma: results of the nuclear medicine credentialing program from the prospective, multi-centre trial evaluating FET PET In Glioblastoma (FIG) study-TROG 18.06Nathaniel Barry, Roslyn J Francis, Martin A Ebert, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
International Journal of Radiation Oncology, Biology, Physics|July 14, 2020
Interim Results of a Prospective Prostate-Specific Membrane Antigen-Directed Focal Stereotactic Reirradiation Trial for Locally Recurrent Prostate CancerSarah Bergamin, Thomas Eade, Andrew Kneebone, et al.
Practical Radiation Oncology|May 7, 2018
Utilizing 18F-fluoroethyltyrosine (FET) positron emission tomography (PET) to define suspected nonenhancing tumor for radiation therapy planning of glioblastomaAimee R Hayes, Dasantha Jayamanne, Edward Hsiao, et al.
Journal of Medical Imaging and Radiation Oncology|January 25, 2019
Influence of molecular classification in anaplastic glioma for determining outcome and future approach to managementMichael Back, Dasantha T Jayamanne, David Brazier, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 2, 2022
<sup>64</sup>Cu Treatment Planning and <sup>67</sup>Cu Therapy with Radiolabeled [<sup>64</sup>Cu/<sup>67</sup>Cu]MeCOSar-Octreotate in Subjects with Unresectable Multifocal Meningioma: Initial Results for Human Imaging, Safety, Biodistribution, and Radiation DosimetryDale L Bailey, Kathy P Willowson, Matthew Harris, et al.
Theranostics|April 25, 2017
Dual Somatostatin Receptor/FDG PET/CT Imaging in Metastatic Neuroendocrine Tumours: Proposal for a Novel Grading Scheme with Prognostic SignificanceDavid Lh Chan, Nick Pavlakis, Geoffrey P Schembri, et al.
Pancreas|February 4, 2020
Evaluation of Fluorodeoxyglucose Positron Emission Tomography Scanning in the Neoadjuvant Therapy Paradigm in Pancreatic Ductal AdenocarcinomaMalinda Itchins, Terence C Chua, Jennifer Arena, et al.
Thyroid Research|June 16, 2025
The utility of <sup>68</sup>Ga-DOTATATE and <sup>18</sup>F-FDG PET/CT in predicting the response to tyrosine kinase inhibitors in patients with advanced medullary thyroid cancerEline C Jager, James McNeil, Alexander J Papachristos, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 10, 2023
Delineation and agreement of FET PET biological volumes in glioblastoma: results of the nuclear medicine credentialing program from the prospective, multi-centre trial evaluating FET PET In Glioblastoma (FIG) study-TROG 18.06Nathaniel Barry, Roslyn J Francis, Martin A Ebert, et al.
Pageof 3